This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.59 which represents a decrease of $-0.02 or -0.08% from the prior close of $26.61. The stock opened at $26.7 and touched a low of ...

UBS lowered the firm’s price target on Pfizer (PFE) to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Pfizer (NYSE: PFE) became a stock market star in early pandemic days as it brought the first coronavirus vaccine to market.

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks targeted by activist hedge funds. Shareholder activism continued at a record pace in ...

Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.4% during trading on Wednesday . The stock traded as high as $26.65 and ...

智通财经APP获悉，美国食品和药物管理局(FDA)表示，葛兰素史克(GSK.US)和辉瑞(PFE.US)生产的一种常见呼吸道病毒疫苗必须附有警告，说明这些疫苗可能会增加一种罕见的神经系统副作用的风险，这种副作用可能导致瘫痪。该机构在周二发布的一份安全 ...

Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.22%. Elsewhere ...